Re: Zenith Capital Corp. to Present on the Emerging Growth Conference on September 25, 2024
posted on
Oct 08, 2024 09:45AM
Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials
Fuzzy
Don't worry - DM stated Zenith shareholders would be receiving a dividend payout this coming February - possibly sooner - he just needs a little cash and a couple of months to finalize the deal.